410 related articles for article (PubMed ID: 17726795)
21. Sitagliptin + metformin: new combination. Do not use this combination. Sitagliptin provides a slight increase of glucose-lowering effects, but there is a disturbing potential for long-term adverse effects: infections, depression, and cancer.
Prescrire Int; 2009 Jun; 18(101):115. PubMed ID: 19637427
[No Abstract] [Full Text] [Related]
22. [Clinical utilization of combined rosiglitazone and glimepiride in the treatment of type 2 diabetes mellitus].
Fehér J; Lengyel G
Orv Hetil; 2007 Dec; 148(49):2331-5. PubMed ID: 18048112
[TBL] [Abstract][Full Text] [Related]
23. A comment on 'the risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy'.
Chang Y; Choi NK; Hahn S; Park BJ
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1072-3; author reply 1073-4. PubMed ID: 17907252
[No Abstract] [Full Text] [Related]
24. Pioglitazone is a valid alternative to rosiglitazone.
Derosa G
Am J Cardiovasc Drugs; 2011 Dec; 11(6):357-62. PubMed ID: 21950735
[TBL] [Abstract][Full Text] [Related]
25. [Oral hypoglycemic therapy of diabetes mellitus].
Montenero P
Minerva Med; 1976 Jan; 67(3):208-15. PubMed ID: 1250219
[No Abstract] [Full Text] [Related]
26. Increased frequency of micronuclei in diabetes mellitus patients using pioglitazone and glimepiride in combination.
Shaik NA; Shaik JP; Ali S; Imran A; Rao DK
Food Chem Toxicol; 2010 Dec; 48(12):3432-5. PubMed ID: 20868721
[TBL] [Abstract][Full Text] [Related]
27. Which should we ADOPT: sulphonylureas or glitazones?
Koshiyama H; Inagaki N; Seino Y
Diabet Med; 2007 Jul; 24(7):804. PubMed ID: 17596243
[No Abstract] [Full Text] [Related]
28. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
[TBL] [Abstract][Full Text] [Related]
29. [New rank order of antidiabetic drugs. Using glitazone before sulfonylurea drugs? (interview by Dr. Dirk Einecke)].
Jacob S
MMW Fortschr Med; 2007 Jan; 149(1-2):14. PubMed ID: 17632857
[No Abstract] [Full Text] [Related]
30. Reducing the Burden of Diabetes Treatment: A Review of Low-cost Oral Hypoglycemic Medications.
Vaughan EM; Rueda JJ; Samson SL; Hyman DJ
Curr Diabetes Rev; 2020; 16(8):851-858. PubMed ID: 32026779
[TBL] [Abstract][Full Text] [Related]
31. The rosiglitazone controversy: the Indian perspective.
Mohan V; Joshi SR
J Assoc Physicians India; 2007 Jul; 55():477-80. PubMed ID: 17907495
[No Abstract] [Full Text] [Related]
32. Type 2 diabetes and oral antihyperglycemic drugs.
Mizuno CS; Chittiboyina AG; Kurtz TW; Pershadsingh HA; Avery MA
Curr Med Chem; 2008; 15(1):61-74. PubMed ID: 18220763
[TBL] [Abstract][Full Text] [Related]
33. [Hypoglycemic sulfamides: new pharmacologic data and practical implications].
Blickle JF; Brogard JM
Diabetes Metab; 1998 Jun; 24(3):276-80. PubMed ID: 9690064
[No Abstract] [Full Text] [Related]
34. [Rosiglitazone: clinical data].
Blickle JF
Ann Endocrinol (Paris); 2002 Apr; 63(2 Pt 2):1S27-33. PubMed ID: 12037505
[No Abstract] [Full Text] [Related]
35. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients: response to Rosenstock et al.
Hamid Z; Simmons DL
Diabetes Care; 2006 Oct; 29(10):2331; author reply 2332. PubMed ID: 17003324
[No Abstract] [Full Text] [Related]
36. The value equation for rosiglitazone and pioglitazone in older persons.
Zarowitz BJ
Geriatr Nurs; 2008; 29(1):9-11. PubMed ID: 18267172
[No Abstract] [Full Text] [Related]
37. Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitus.
Schöndorf T; Lübben G; Hoopmann M; Borchert M; Forst T; Hohberg C; Löbig M; Armbruster FP; Roth W; Grabellus M; Pfützner A
Gynecol Endocrinol; 2007 Jun; 23(6):356-60. PubMed ID: 17616862
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacologic treatment of diabetes].
De Montigny P; Clerc C; Descarpentries C
Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094
[No Abstract] [Full Text] [Related]
39. A case of rosiglitazone exposure in the second trimester of pregnancy.
Kalyoncu NI; Yaris F; Ulku C; Kadioglu M; Kesim M; Unsal M; Dikici M; Yaris E
Reprod Toxicol; 2005; 19(4):563-4. PubMed ID: 15749272
[TBL] [Abstract][Full Text] [Related]
40. Sulphonylureas in the treatment of non-insulin-dependent diabetes.
Ferner RE; Alberti KG
Q J Med; 1989 Nov; 73(271):987-95. PubMed ID: 2695959
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
